Should I Buy LGND Stock in 2026?
Data-driven analysis and honest assessment for Ligand Pharmaceuticals Inc
Current Price: $231.82P/E: 37.8
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
High P/E of 37.8 indicates premium
Slow growth of 1%
Thin margins (0% net)
Financial health data limited
Low FCF yield of 1.2%
No recent insider activity
Key Investment Metrics
Current Price
$231.82
P/E Ratio
37.82
Revenue Growth
0.4%
Profit Margin
0.5%
Market Cap
$4.6B
Dividend Yield
None
How LGND Compares to Competitors
Understanding how LGND stacks up against peers helps inform your investment decision.
How LGND Compares to Peers
Upcoming Events for LGND
+5 Reasons TO Buy LGND
1. High gross margins of 64%
moderateGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy LGND
1. Thin profit margins of 0.5%
high riskLow margins provide little cushion against cost increases or pricing pressure.
2. Premium valuation at 38x earnings
medium riskP/E of 38 requires sustained growth to justify. Multiple compression risk exists.
3. Minimal revenue growth
low riskGrowth of 0.4% barely keeps pace with inflation.
4. Low free cash flow yield of 1.2%
low riskLimited cash generation means most value comes from future growth expectations.
Who Should Buy LGND?
Investment Profile
Risk Level
High
Recommended Holding Period
3-5 years
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Value Investors
Premium P/E of 38 doesn't fit value criteria
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
Consider These Alternatives
If you're interested in LGND, compare these Health Care peers:
Pro tip: Compare LGND directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for LGND
Frequently Asked Questions
What is LGND stock price today?
LGND (Ligand Pharmaceuticals Inc) stock is trading at $231.82 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is LGND stock going up or down today?
LGND stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy LGND stock now?
The decision to buy LGND depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is LGND a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for LGND based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is LGND stock overvalued or undervalued?
LGND currently trades at a P/E ratio of 37.82, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if LGND is fairly priced.
What is LGND's P/E ratio?
LGND has a price-to-earnings (P/E) ratio of 37.82, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is LGND's market cap?
LGND (Ligand Pharmaceuticals Inc) has a market capitalization of $4.62 billion, making it a small-cap stock.
What is LGND's price to book ratio?
LGND trades at a price-to-book (P/B) ratio of 4.38, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Ligand Pharmaceuticals Inc
Full Stock Analysis
Complete LGND overview with charts and data
Is LGND Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how LGND stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Ligand Pharmaceuticals Inc
Complete LGND Analysis
Compare LGND With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.